Arca
Skip to content
Tools
Tools

N Latex Igm

Method, Nephelometric, Immunoglobulins (G, A, M). 510(k) K032014, from Dade Behring, Inc. (Newark, DE). Product code CFN, class 2.

As of Nov 19, 2026, K032014 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Aug 7, 2003 after 38 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 38 days
  • Recalls: 1

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

N Latex IgM is an in vitro diagnostic test for the quantitative determination of IgM in human cerebrospinal fluid (CSF) and in paired CSF/serum samples by means of particle-enhanced immunonephelometry using the BN TM Systems. The determination of IgM aids in the evaluation of the patient's immune system.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Recalls

Recalls FDA ties to K032014, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Jan 15, 2015Z-1289-2015Complaints have been confirmed on failed proficiency testing due to serum samples recovering too low when using some N Latex IgM reagent kit lots 44018, 44019 and 44042.Terminated

Other CFN clearances

The newest 510(k)s for the same product code; see every CFN device

Record

Type
Traditional
Received
Jun 30, 2003
Review panel
Immunology
Regulation
21 CFR 866.5510

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.